View document text
Registered Office / Factory :
Village Kumbhivali, Savroli-Kharpada
Road, Khalapur-410 202,
Dist. Raigad (Maharashtra)
Tel. 02192 - 276140
Date: November 17, 2026
BSE Limited The National Stock Exchange of India Limited
Listing & Compliance Department Listing & Compliance Department
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1 Block G,
Dalal Street, Fort Bandra Kurla Complex,
Mumbai – 400001. Bandra (E), Mumbai – 400051
Scrip: 514418 Symbol: MANORG
Dear Sir/Madam,
Sub: Investor Presentation for Second Quarter and Half Year ended September 30,
2026 under Regulation 30 of Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)
Pursuant to Regulation 30 of the Listing Regulations, we hereby enclose a copy of Investor
Presentation for Second Quarter and Half Year ended September 30, 2026.
This Investor Presentation may also be accessed on the website of the Company at
www.mangalamorganics.com.
Request you to kindly take the same on record.
Thanking you,
Yours faithfully,
For Mangalam Organics Limited
Charmi Shah
Company Secretary & Compliance Officer
Encl: As above
An ISO 9001/14001/45001
2018 Certified Company
SAFE HARBOR
This presentation and the accompanying slides (the “Presentation”), which have been prepared by Mangalam Organics Limited (the
“Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase
or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment
whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed
information about the Company.
This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the
Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy,
completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not
contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this
Presentation is expressly excluded
Certain matters discussed in this Presentation may contain statements regarding the Company’s market opportunity and business prospects
that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance
and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. These risks and uncertainties
include, but are not limited to, the performance of the Indian economy and of the economies of various international markets, the
performance of the industry in India and world-wide, competition, the company’s ability to successfully implement its strategy, the
Company’s future levels of growth and expansion, technological implementation, changes and advancements, changes in revenue, income or
cash flows, the Company’s market preferences and its exposure to market risks, as well as other risks. The Company’s actual results, levels of
activity, performance or achievements could differ materially and adversely from results expressed in or implied by this Presentation. The
Company assumes no obligation to update any forward-looking information contained in this Presentation. Any forward-looking statements
and projections made by third parties included in this Presentation are not adopted by the Company and the Company is not responsible for
such third-party statements and projections.
Our Product Portfolio – B2B
TERPENE
SYNTHETIC RESINS
Revenue break-up of
Mangalam Organics Limited
Our Business Segments
B2B- Terpene
B2B- Synthetic
B2C – Retail
Resin
Operations
•Camphor: Religious use,
healthcare products,
•Terpene Phenolic •Campure -
hygiene products
Resin- Adhesives, Homecare and
Tyres, Rubbers, Personal Care
•Dipentene: Paints, Chewing Gum, Product based on
cleaning and degreasing camphor
agents
•Alkyl Phenolic
Resin- Printing Ink •Mangalam -
•Sodium Acetate: Textile Camphor tablets for
and dyes industry, pious uses, Private
•Resin Esters
Leather tanning labelling Initiatives
•lsobornyl Acetate,
•lsoborneol
Our Product Portfolio – B2C ( MANGALAM )
CCoonnssuummeerr--FFooccuusseedd
BBuussiinneessss
Mangalam - Camphor tablets for pious uses Private Labelling Initiatives
Our Product Portfolio – B2C ( CAMPURE )
Consumer-Focused
Business
CamPure - Homecare and personal care products based on Camphor
Our Business Model
A robust and integrated model that creates value at every step
Cost
Chemistry B2C Retailing Competitive
Advantage
Capabilities Expertise Edge
High Product
Strong R&D and Strong consumer High Product
quality, innovation
deep chemistry connect and retail quality, innovation
and operational
expertise enable us capabilities help us and operational
efficiencies give us a
to develop high reach customers efficiencies give us
sustainable edge in
quality and effectively and build a sustainable edge
a competitive
innovative products trusted brands in a competitive
market
market
FY26 Consolidated Financial Performance
Revenues (Rs. Crs) EBITDA (Rs. Crs) PAT (Rs. Crs)
+17.46 %
+ 49.91 % +103.04%
622.57
530.00
87.82
25.38
58.58
12.50
FY26 FY25 FY26 FY25 FY26 FY25
EBITDA Margin (%) PAT Margin (%) • Revenue growth of 17.46 % in FY26 vs
FY25.
+306
+ 172 bps
• Decrease in input costs lead to
profitability for the year.
14.11%
4.08%
11.05%
2.36% • Company continues its efforts on
improving efficiencies and margins
going forward.
FY26 FY25 FY26 FY25 10
QOQ FY27 Q2 Consolidated Financial Performance
Revenues (Rs. Crs) EBITDA (Rs. Crs) PAT (Rs. Crs)
78.02 % 7596%
281.46
158.10
21.55
0.28 3.02 3.02
Q2 FY27 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 Q2 FY26
EBITDA Margin (%) PAT Margin (%)
-88 bps
+748 bps
Revenue Growth of 78.02 % in Q2 FY27 as compared to
Q2 FY26.
Continued focus on enhancing operational efficiencies
andstrengtheningmarginsgoing forward.
7.66% 0.18%
1.14% 2.02%
Q2 FY27 Q2 FY26 Q2 FY27 Q2 FY26 11
Q1 FY27 Consolidated Profit & Loss Statement
Q2FY27 Q2 FY26 Y-o-Y (%) Q1FY27 Q-O-Q FY26 FY25 Y-o-Y (%)
Particulars (Rs. Crs)
Revenue from Operations 281.46 158.10 78.03 179.09 57.16 622.57 530.01 17.46
Cost of Materials Consumed 199.45 99.67 122.89 365.34 312.47
Purchase of stock in trade 0.09 3.94 0.04 7.87 6.86
Changes in Inventories of finished goods, work in
-1.15 -1.03 -19.97 -45.18 -45.85
progress and stock-in trade
Gross Profit 83.07 55.52 49.62 76.13 9.12 294.54 256.53 14.82
GP % 29.5 35.1 42.5 47.3 48.4
Employee Benefits Expense 14.13 12.08 13.55 49.92 41.54
Other Expenses 47.39 43.16 40.37 156.80 156.41
EBITDA 21.55 0.28 7596 22.21 -2.97 87.82 58.58 49.91
EBITDA % 7.66 0.18 12.40 14.11 11.05
Other Income 0.05 20.54 0.07 4.75 0.33
Depreciation and Amortisation Expense 7.51 6.13 6.16 27.58 20.82
EBIT 14.09 14.69 -4.08 16.12 -12.59 64.99 38.09 70.62
Finance Costs 9.09 6.99 7.42 28.19 21.47
PBT 5 7.7 -35.06 8.7 -42.53 36.8 16.61 121.55
Less: Exceptional Loss 0 3.5 - 0 -3.5 -
PBT after Exceptional Loss 5 4.18 - 8.7 33.3 -
Less: Tax Expense 1.8 0.98 1.43 7.92 4.11
Profit for the year 3.2 3.2 0.00 7.27 -55.98 25.38 12.5 103.04
PAT % 1.14 2.02 4.06 4.08 2.36
EPS 3.74 3.73 8.49 29.64 14.6
Profit & Loss Statement (Audited) as on March 2026
Particulars (Rs. Crs) FY26 FY25 FY24 FY23
Revenue from Operations 622.57 530.01 493.52 492.5
Cost of Materials Consumed 365.34 312.47 258.93 409.4
Purchase of stock in trade 7.87 6.86 6.37 6.5
Changes in Inventories of finished goods, work in progress and stock-in trade -45.18 -45.85 37.37 -72.7
Gross Profit 294.54 256.53 190.85 149.3
GP % 47.3 48.40 38.67 30.31
Employee Benefits Expense 49.92 41.54 39.07 34.7
Other Expenses 156.80 156.4 113.11 117.4
EBITDA 87.82 58.59 38.67 -2.8
EBITDA % 14.11 11.05 7.84 -0.57
Other In
[Showing first 8,000 characters — download PDF for full document]